ACHE and Alzheimer disease: At the time of the study all participants were on a stable treatment for AD (acetylcholinesterase inhibitor, memantin or combination) for at least 6 months and did not receive any other medication that could influence cognitive functioning (e.g. benzodiazepines, sleep aids, neuroleptics).